• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白E小鼠的病理生理学特征:糖尿病和动脉粥样硬化模型

Pathophysiological characterization of the ApoE mouse: A model of diabetes and atherosclerosis.

作者信息

Paniagua-Sancho María, Casanova Alfredo G, Rodríguez-Estévez Lucía, Cruz-González Ignacio, López-Hernández Francisco J, Martínez-Salgado Carlos

机构信息

Translational Research On Renal and Cardiovascular Diseases (TRECARD), Department of Physiology and Pharmacology, University of Salamanca, 37007 Salamanca, Spain; Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain.

Cardiology Department, University Hospital of Salamanca, 37007 Salamanca, Spain.

出版信息

Methods. 2025 Feb;234:223-232. doi: 10.1016/j.ymeth.2025.01.002. Epub 2025 Jan 4.

DOI:10.1016/j.ymeth.2025.01.002
PMID:39761864
Abstract

The high prevalence of type 2 diabetes and atherosclerosis makes essential the availability of in vivo experimental models that accurately replicate the pathophysiological mechanisms of these diseases. Apolipoprotein E knockout mice (ApoE) have been used in atherosclerosis studies, and the db/db mice show hyperphagia and obesity. Mice harbouring both alterations (i.e., ApoE) are expected to develop combined features of type 2 diabetes, obesity and accelerated atherosclerosis. To deepen into their pathophysiological profile and further assess their potential as an experimental model, we studied their mortality and their pancreatic, cardiac, and renal phenotype. We analysed during 6 months the glycemic and lipid profile, pancreatic, cardiac and renal structure and function and atherosclerosis in ApoE mice. ApoE mice show increases in plasma glucose (although without statistical significance) and glucagon levels, total cholesterol, triglycerides and HDL-cholesterol and in both insulin-producing β and glucagon producing α cells, and in the tissue expression of both hormones with respect to control (C57BL/6) mice; they show a remarkably high degree of atherosclerosis, higher left ventricular ejection fraction. Although renal function is normal, glucose, sodium and albumin excretion and urinary flow are increased with respect to control mice. Summarizing, ApoE mice constitute a suitable experimental model for the study of type 2 diabetes associated with atherosclerosis.

摘要

2型糖尿病和动脉粥样硬化的高患病率使得准确复制这些疾病病理生理机制的体内实验模型变得至关重要。载脂蛋白E基因敲除小鼠(ApoE)已用于动脉粥样硬化研究,而db/db小鼠表现出食欲亢进和肥胖。同时具有这两种改变(即ApoE)的小鼠预计会出现2型糖尿病、肥胖和加速动脉粥样硬化的综合特征。为了深入了解它们的病理生理特征并进一步评估它们作为实验模型的潜力,我们研究了它们的死亡率以及胰腺、心脏和肾脏表型。我们在6个月内分析了ApoE小鼠的血糖和血脂谱、胰腺、心脏和肾脏结构与功能以及动脉粥样硬化情况。ApoE小鼠的血糖(尽管无统计学意义)和胰高血糖素水平、总胆固醇、甘油三酯和高密度脂蛋白胆固醇升高,胰岛素分泌β细胞和胰高血糖素分泌α细胞以及这两种激素的组织表达相对于对照(C57BL/6)小鼠均增加;它们表现出高度显著的动脉粥样硬化,左心室射血分数更高。尽管肾功能正常,但相对于对照小鼠,葡萄糖、钠和白蛋白排泄以及尿流量增加。总之,ApoE小鼠构成了研究与动脉粥样硬化相关的2型糖尿病的合适实验模型。

相似文献

1
Pathophysiological characterization of the ApoE mouse: A model of diabetes and atherosclerosis.载脂蛋白E小鼠的病理生理学特征:糖尿病和动脉粥样硬化模型
Methods. 2025 Feb;234:223-232. doi: 10.1016/j.ymeth.2025.01.002. Epub 2025 Jan 4.
2
Increased hypercholesterolemia and atherosclerosis in mice lacking both ApoE and leptin receptor.缺乏载脂蛋白E和瘦素受体的小鼠中高胆固醇血症和动脉粥样硬化加剧。
Atherosclerosis. 2005 Aug;181(2):251-9. doi: 10.1016/j.atherosclerosis.2005.01.029. Epub 2005 Feb 24.
3
Hyperglycemia in apolipoprotein E-deficient mouse strains with different atherosclerosis susceptibility.载脂蛋白 E 缺陷型小鼠在不同动脉粥样硬化易感性中的高血糖症。
Cardiovasc Diabetol. 2011 Dec 28;10:117. doi: 10.1186/1475-2840-10-117.
4
Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.载脂蛋白E缺乏可消除2型糖尿病小鼠模型中的胰岛素抵抗。
Diabetologia. 2009 Jul;52(7):1434-41. doi: 10.1007/s00125-009-1378-8. Epub 2009 May 13.
5
Sex differences in the development of vascular and renal lesions in mice with a simultaneous deficiency of and the integrin chain .同时缺乏 和整合素链 的小鼠血管和肾脏病变发展中的性别差异
Biol Sex Differ. 2017 May 30;8:19. doi: 10.1186/s13293-017-0141-y. eCollection 2017.
6
Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.载脂蛋白 E 基因敲除作为脂代谢紊乱诱导的周围神经病小鼠模型的基础。
Exp Neurol. 2013 Jan;239:102-10. doi: 10.1016/j.expneurol.2012.10.002. Epub 2012 Oct 8.
7
A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.一种新型糖尿病、动脉粥样硬化和脂肪肝疾病的小鼠模型,通过 AAV8-PCSK9-D377Y 注射和 db/db 小鼠的饮食干预来建立。
Biochem Biophys Res Commun. 2022 Sep 24;622:163-169. doi: 10.1016/j.bbrc.2022.07.031. Epub 2022 Jul 15.
8
Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1.载脂蛋白 E 基因敲除小鼠胰岛素受体及其底物 1 杂合子加速动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):247-56. doi: 10.1161/ATVBAHA.111.240358. Epub 2011 Dec 22.
9
Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.钠-葡萄糖协同转运蛋白2抑制剂改善高血糖通过抑制1型和2型糖尿病小鼠巨噬细胞泡沫细胞形成预防巨噬细胞驱动的动脉粥样硬化。
PLoS One. 2015 Nov 25;10(11):e0143396. doi: 10.1371/journal.pone.0143396. eCollection 2015.
10
Protective effect of betulinic acid on early atherosclerosis in diabetic apolipoprotein-E gene knockout mice.桦木酸对糖尿病载脂蛋白E基因敲除小鼠早期动脉粥样硬化的保护作用。
Eur J Pharmacol. 2017 Feb 5;796:224-232. doi: 10.1016/j.ejphar.2016.11.044. Epub 2016 Nov 26.

引用本文的文献

1
Current status and challenges of multi-omics research using animal models of atherosclerosis.使用动脉粥样硬化动物模型进行多组学研究的现状与挑战
J Mol Cell Cardiol Plus. 2025 Jul 10;13:100476. doi: 10.1016/j.jmccpl.2025.100476. eCollection 2025 Sep.
2
Adipose Tissue-Derived Adipokines in Vascular Physiology and Pathophysiology: Insights and Implications.脂肪组织衍生的脂肪因子在血管生理与病理生理中的作用:见解与启示
Compr Physiol. 2025 Jun;15(3):e70018. doi: 10.1002/cph4.70018.